Gowling WLG advised AstraZeneca on the transaction. AstraZeneca started a collaboration with Scorpion Therapeutics, Inc. (“Scorpion”) to develop precision medicines against previously hard-to-target cancer proteins. Scorpion will...
You must be a Standard 1 Year member to access this content.
Gowling WLG’s advised Sosei Heptares on the deal. Sosei Heptares on its collaboration with San Diego based Neurocrine Biosciences Inc to develop novel muscarinic receptor agonist...
You must be a Standard 1 Year member to access this content.
Gowling WLG advised Eisai Co., Ltd. on the deal. Morgan Lewis advised Advanz Pharma. Eisai Co., Ltd. agreed to divest its rights for the antiepileptic agent...
You must be a Standard 1 Year member to access this content.
